- Poster presentation
- Open Access
Serum and molecular assessment of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1α (HIF-1α) in canine mammary tumors
© Moschetta et al; licensee BioMed Central Ltd. 2013
- Published: 4 April 2013
- Vascular Endothelial Growth Factor
- Clinicopathological Feature
- Mammary Tumor
- Clinicopathological Parameter
- Excellent Model
Due to the many similarities shared by humans and dogs, canine mammary tumors are an excellent model to comprehend various aspects of mammary neoplasias. The tumor cells have the ability to promote changes in their functionality in order to survive. In situations of hypoxia, tumor cells produce and release pro and antiangiogenic factors that regulate the process of angiogenesis. The hypoxia-inducible factor 1 (HIF -1) is a central regulator of pathophysiological response of mammalian cells to low oxygen levels, able to activate transcription of the gene that promotes the induction of vascular endothelial growth factor (VEGF),which in turn, promotes angiogenesis through its ability to stimulate growth, migration and invasion of endothelial cells, leading to the formation of new blood vessels and subsequent tumor growth. In this context, the aim of this study was to measure serum levels of VEGF and HIF-1 and to relate with clinicopathological parameters and survival.
Through enzyme-linked immunosorbent assay and qPCR were evaluated and statistically related 30 female dogs with mammary tumor and 47 controls.
High levels of VEGF were correlated with abundant irrigation (p=0.02), metastase (p=0.003), death (p=0.001) and low survival (p<0.0001); however HIF-1 levels was not related with clinicopathological features investigated. The VEGF was superexpressed in tumors with abundant irrigation and also in female dogs with metastase, recidive and death while the HIF-1α was underexpressed.
Our results show that these proteins play an important role in angiogenesis and are useful in predicting tumor progression in canine mammary tumors.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.